Condition: VEXAS · Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
This multicenter cross-sectional observational study aims to describe health-related quality of life (HRQoL) and symptom profiles of patients with VEXAS syndrome.
This description comes directly from the study's public registry record.
Fabio Efficace · +39 06 441639831 · f.efficace@gimema.it
Always discuss trial participation with your own doctor first.
| Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica | Ancona, Italy | Recruiting |
| Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia | Bergamo, Italy | Recruiting |
| Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia | Bologna, Italy | Recruiting |
| Asst Degli Spedali Civili Di Brescia - Uo Ematologia | Brescia, Italy | Recruiting |
| Istituto Di Candiolo - Fondazione Del Piemonte Per L'Oncologia - Irccs - Centro Trapianti | Candiolo, Italy | Recruiting |
| Aou Careggi - Firenze - Sod Ematologia | Florence, Italy | Recruiting |
| Fondazione Irccs Ca' Granda, Ospedale Maggiore Policlinico - Milano - Ematologia - Padiglione Marcora | Milan, Italy | Recruiting |
| Irccs Ospedale S. Raffaele - Milano - Uo Oncoematologia | Milan, Italy | Recruiting |
| Aou Federico Ii - Napoli - Uoc Ematologia | Naples, Italy | Recruiting |
| Aou Di Padova - Uo Ematologia | Padova, Italy | Recruiting |
| Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia | Pavia, Italy | Recruiting |
| Ausl Di Reggio Emilia - Arcispedale Santa Maria Nuova, Irccs - Sc Ematologia | Reggio Emilia, Italy | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06657846